Teva Pharmaceuticals

@TevaUSA ↗

Deleted No

Hibernated No

Last Checked April 3, 2023

Created

Mon Nov 07 20:31:47 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Teva Pharmaceuticals @TevaUSA

The passage of #GDUFA III signals a step in the right direction for generic access for patients and increasing competition for industry members while improving the overall healthcare infrastructure – Teva’s Brian McCormick remarked @AccessibleMeds #GRxBiosims https://t.co/8FDXWoikxz — PolitiTweet.org

Posted Nov. 7, 2022

Preceded By

Teva Pharmaceuticals @TevaUSA

Teva’s @RachelTurow will be at the Interchangeability panel at #GrXBiosims sharing her experience with biosimilar development and FDA’s approval pathway – and what can be done to improve it. https://t.co/e05gHZ3UCs — PolitiTweet.org

Posted Nov. 7, 2022

Followed By

Teva Pharmaceuticals @TevaUSA

The current regulatory framework for biosimilars and determining interchangeability within the US is not sustainable. @RachelTurow is live at #GRxBiosims discussing how we can break down unnecessary barriers and drive uptake– with savings to patients and the US healthcare system. https://t.co/mcpSJQYNiX — PolitiTweet.org

Posted Nov. 7, 2022